Total Funding
59
59
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
68160
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.
- Stephen Bloch: Co-Founder and CEOPast Role: OmniSonics Medical Technologies, Team Member
- Stephen M. Strittmatter: Co-Founder
About the Company
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug capable of delivering a disease-modifying approach and preserving cognition in
patients.
